Ari Bousbib

Selected news for the person - Ari Bousbib, collected since 10/2017. Recent stories appear in Becker's Hospital Review and alphastreet.com. This person shares healthcare news with IQVIA, IQVIA Holdings, Quintiles and many others.

Please provide a valid email address.
Shares Healthcare News With (link):
Healthcare Topics
Companies

Selected Headlines

Date Headline (link) Source Relevant Snippet
6/1/2021 15 top-paid S&P 500 healthcare CEOs Becker's Hospital Review ... 73.4 million 3. Samuel Hazen, CEO of Nashville, Tenn.-based HCA Healthcare: $30.4 million 4. Alex Gorsky, CEO of Johnson & Johnson: $29.6 million 5. Marc Casper, CEO of Thermo Fisher Scientific: $26.4 million 6. Ari Bousbib , CEO of Iqvia: $25.6 million 7. Michael Neidorff, CEO of Centene: $25 million 8. Richard Gonzalez, CEO of AbbVie: $24 million 9. David Ricks, CEO of Eli Lilly: $23.7 million 10. Larry Merlo, CEO ...
4/23/2021 IQVIA Holdings Inc. (IQV) Q1 2021 Earnings Call Transcript alphastreet.com Categories Earnings Call Transcripts, Health Care IQVIA Holdings Inc. (NYSE: IQV) Q1 2021 Earnings Call dated Apr. 22, 2021. Andrew Markwick — Senior Vice President, Investor Relations and Treasury Ari Bousbib — Chairman and Chief Executive Officer Ron Bruehlman — Executive Vice President and Chief Financial Officer Robert Jones — Goldman Sachs — Analyst Eric Coldwell — Baird — Analyst Shlomo Rosenbaum — Stifel — Analyst John Kreger — William ...
10/16/2020 Ari Bousbib 69,120 Iqvia Holdings Inc (NYSE:IQV) Daily Political Iqvia Holdings Inc (NYSE:IQV) insider Ari Bousbib sold 69,120 shares of Iqvia that occurred on Monday, October 12th. The shares were sold $170.00, for a total transaction of $11,750,400.00. Following the sale, the insider now directly owns 721,155 shares in the company, valued at $122,596,350. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink . Ari Bousbib also recently made the following ...
8/21/2020 Ari Bousbib Sells 69,120 Shares of Iqvia Holdings Inc (NYSE:IQV) Stock dispatchtribunal.com Iqvia Holdings Inc (NYSE:IQV) insider Ari Bousbib sold 69,120 shares of the stock in a transaction that occurred on Friday, August 14th. The shares were sold at an average price of $161.66, for a total value of $11,173,939.20. Following the completion of the sale, the insider now directly owns 721,155 shares of the company’s stock, valued at approximately $116,581,917.30. The transaction was disclosed in a document filed with the ...
8/20/2020 Ari Bousbib Sells 69,120 Iqvia Holdings Inc (NYSE:IQV) Daily Political Iqvia Holdings Inc (NYSE:IQV) insider Ari Bousbib sold 69,120 shares of the firm’s stock in a transaction dated Friday, August 14th. The stock was sold at an average price of $161.66, for a total transaction of $11,173,939.20. Following the completion of the transaction, the insider now owns 721,155 shares of the company’s stock, valued at $116,581,917.30. The sale was disclosed in a document filed with the Securities & Exchange Commission ...
8/19/2020 Iqvia Holdings Inc (NYSE:IQV) Insider Ari Bousbib Sells 69,120 Shares equitiesfocus.com Iqvia Holdings Inc (NYSE:IQV) insider Ari Bousbib sold 69,120 shares of Iqvia stock in a transaction dated Friday, August 14th. The stock was sold at an average price of $161.66, for a total value of $11,173,939.20. Following the completion of the sale, the insider now directly owns 721,155 shares in the company, valued at $116,581,917.30. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which ...
8/19/2020 Iqvia Holdings Inc (NYSE:IQV) Insider Ari Bousbib Sells 69,120 Shares American Banking News Iqvia Holdings Inc (NYSE:IQV) insider Ari Bousbib sold 69,120 shares of Iqvia stock in a transaction dated Friday, August 14th. The stock was sold at an average price of $161.66, for a total value of $11,173,939.20. Following the completion of the sale, the insider now directly owns 721,155 shares in the company, valued at $116,581,917.30. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which ...
8/19/2020 Insider Selling: Iqvia Holdings Inc (NYSE:IQV) Insider 69,120 of Stock - theolympiareport.com Iqvia Holdings Inc (NYSE:IQV) insider Ari Bousbib sold 69,120 shares of the dated Friday, August 14th. The shares were sold $161.66, for a total transaction of $11,173,939.20. Following the completion of the sale, the insider now owns 721,155 stock, valued at approximately $116,581,917.30. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink . Ari Bousbib also recently made the following trade(s): Get ...
8/5/2020 IQVIA’s Nancy Dreyer and Deepa Desai Honored with 2020 PharmaVOICE Awards | Business Wire Business Wire ... the 2020 PharmaVOICE 100 List, which identifies the most influential and inspiring leaders within the life sciences industry. “Congratulations to Nancy and Deepa for receiving these greatly deserved honors,” said IQVIA CEO and Chairman Ari Bousbib . “We are proud of their impactful accomplishments. These awards speak to their strong leadership, vision and strategic abilities to continue to create lasting change within the life sciences industry.” Nancy Dreyer has been at ...
8/5/2020 IQVIA’s Nancy Dreyer and Deepa Desai Honored with 2020 PharmaVOICE Awards BioSpace ... the 2020 PharmaVOICE 100 List, which identifies the most influential and inspiring leaders within the life sciences industry. “Congratulations to Nancy and Deepa for receiving these greatly deserved honors,” said IQVIA CEO and Chairman Ari Bousbib . “We are proud of their impactful accomplishments. These awards speak to their strong leadership, vision and strategic abilities to continue to create lasting change within the life sciences industry.” Nancy Dreyer has been at ...
8/5/2020 IQVIA’s Nancy Dreyer and Deepa Desai Honored with 2020 PharmaVOICE Awards gurufocus.com ... the 2020 PharmaVOICE 100 List, which identifies the most influential and inspiring leaders within the life sciences industry. “Congratulations to Nancy and Deepa for receiving these greatly deserved honors,” said IQVIA CEO and Chairman Ari Bousbib . “We are proud of their impactful accomplishments. These awards speak to their strong leadership, vision and strategic abilities to continue to create lasting change within the life sciences industry.” Nancy Dreyer has been at ...
8/3/2020 Iqvia Holdings Inc (NYSE:IQV) Short Interest Update American Banking News ... 2,940,000 shares. Currently, 1.3% of the company’s stock are sold short. Based on an average daily volume of 1,230,000 shares, the days-to-cover ratio is presently 2.0 days. In other Iqvia news, insider Ari Bousbib sold 19,443 shares of the firm’s stock in a transaction dated Monday, June 1st. The stock was sold at an average price of $150.00, for a total value of $2,916,450.00. Following the completion of ...
7/23/2020 IQVIA Holdings Inc. (IQV) Q2 2020 Earnings Call Transcript alphastreet.com ... begin your conference. Andrew Markwick — Senior Vice President, Investor Relations and Treasury Thank you. Good morning, everyone. Thank you for joining our second quarter 2020 earnings call. With me on the call today are Ari Bousbib , Chairman and Chief Executive Officer; Michael McDonnell, Executive Vice President and Chief Financial Officer; Ron Bruehlman, who will be Mike’s successor, as of August 1st; Eric Sherbet, Executive Vice President and General Counsel; Nick ...
7/22/2020 IQVIA Appoints Ron Bruehlman Executive Vice President and interim Chief Financial Officer Business Wire ... until the merger of IMS Health and Quintiles in 2016. Since the merger, Ron has continued to play an active role on the executive leadership team at IQVIA, serving as a senior advisor to Ari Bousbib , Chairman and CEO of IQVIA. During this time, Ron regularly participated in key management meetings, operational reviews, preparation of quarterly earnings reports, and board meetings, providing on-going guidance and support to Mike and ...
7/22/2020 IQVIA moves Bruehlman into chief financial exec role as sales fall amid pandemic FierceBiotech ... been CFO at IMS Health for five years until it merged with Quintiles in 2016, becoming IQVIA. Since the merger, Bruehlman stepped away from the financial role and into an advisory one for CEO Ari Bousbib . The seat, however, is not his long-term plan ; he’s stepping in while the company seeks a full-time replacement for McDonnell, who announced his departure this week. “I am excited to continue serving ...
7/22/2020 IQVIA Appoints Ron Bruehlman Executive Vice President and interim Chief Financial Officer pharmaceuticaldaily.com ... until the merger of IMS Health and Quintiles in 2016. Since the merger, Ron has continued to play an active role on the executive leadership team at IQVIA, serving as a senior advisor to Ari Bousbib , Chairman and CEO of IQVIA. During this time, Ron regularly participated in key management meetings, operational reviews, preparation of quarterly earnings reports, and board meetings, providing on-going guidance and support to Mike and ...
7/22/2020 IQVIA Reports Second-Quarter 2020 Results and Raises Full-Year 2020 Guidance BioSpace ... 0.12). Adjusted Net Income was $229 million and Adjusted Diluted Earnings per Share was $1.18. “Against the background of the ongoing COVID-19 situation, we delivered second quarter results that exceeded our expectations,” said Ari Bousbib , chairman and CEO of IQVIA. “As we had assumed, the R&DS business saw a gradual increase in the accessibility of clinical research sites, exiting the quarter at 40 percent accessibility and currently at ...
7/22/2020 IQVIA Holdings Inc. (IQV) Q2 2020 Earnings Call Transcript | The Motley Fool fool.com ... begin your conference. Andrew Markwick -- Senior Vice President, Investor Relations and Treasury Thank you. Good morning, everyone. Thank you for joining our second quarter 2020 earnings call. With me on the call today are Ari Bousbib , Chairman and Chief Executive Officer; Michael McDonnell, Executive Vice President and Chief Financial Officer; Ron Bruehlman, who will be Mike's successor, as of August 1st; Eric Sherbet, Executive Vice President and General Counsel; Nick ...
7/21/2020 IQVIA Appoints Ron Bruehlman Executive Vice President and interim Chief Financial Officer | Business & Finance | heraldchronicle.com Business Wire ... until the merger of IMS Health and Quintiles in 2016. Since the merger, Ron has continued to play an active role on the executive leadership team at IQVIA, serving as a senior advisor to Ari Bousbib , Chairman and CEO of IQVIA. During this time, Ron regularly participated in key management meetings, operational reviews, preparation of quarterly earnings reports, and board meetings, providing on-going guidance and support to Mike and ...
7/21/2020 IQVIA Appoints Ron Bruehlman Executive Vice President and interim Chief Financial Officer Benzinga ... until the merger of IMS Health and Quintiles in 2016. Since the merger, Ron has continued to play an active role on the executive leadership team at IQVIA, serving as a senior advisor to Ari Bousbib , Chairman and CEO of IQVIA. During this time, Ron regularly participated in key management meetings, operational reviews, preparation of quarterly earnings reports, and board meetings, providing on-going guidance and support to Mike and ...